Researchers track long-term effects of romiplostim in aplastic anemia patients
NCT ID NCT04870346
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 32 times
Summary
This study follows people with aplastic anemia who previously received the drug romiplostim in earlier clinical trials. The goal is to see how well the treatment works over up to 5 years and to monitor any long-term side effects, such as new chromosome changes or blood cancers. About 36 participants are being observed, but no new treatment is given during this follow-up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kanazawa University, College of Medical Pharmaceutical and Health Sciences, School of Medicine, Department of Hematology
Kanazawa, Ishikawa-ken, 920-0934, Japan
Conditions
Explore the condition pages connected to this study.